Journey Energy Inc. (TSX: JOY) (OTCQX: JRNGF) (“Journey” or the “Company”) is pleased to report its year-end 2025 oil and gas ...
ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
Q4 2025 Earnings Call February 25, 2026 2:00 AM ESTCompany ParticipantsNina Grieg - Chief Executive OfficerMagnus Johannesen ...
Aspocomp estimates that its net sales for 2026 will grow, and that its operating result for 2026 will improve compared to 2025. In 2025, net sales amounted to EUR 38.2 million, and the operating ...
GST is paid by the e-commerce operator and not the supplier. Therefore, composition dealers are not restricted from supplying ...
University prestige may not be the key to career success. Discover research on what truly impacts success and why mentorship, not brand, might matter more.
Discover how to calculate free cash flow (FCF) to evaluate financial health, assess company value, and make informed ...
Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, Feb. /CNW/ — USA News Group News Commentary, The global oncology market is on track to nearly triple in value over the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results